A new standard of care for patients with high-risk rhabdomyosarcoma?

Lancet Oncology, jan 2020

Italiano, A.

https://www.ncbi.nlm.nih.gov/pubmed/31908302

doi : 10.1016/S1470-2045(19)30784-3